Robert Hill is the founder of TAE Life Sciences. TAE Life Sciences has raised $70M in total funding. Latest round: Series B. Based in Irvine, CA.
Robert Hill serves as the Chief Executive Officer (CEO) of TAE Life Sciences, a pre-clinical biotech company specializing in accelerator-based Boron Neutron Capture Therapy (BNCT) for radiation oncology. He was promoted to this role in July 2023. Under his leadership, the company has secured Series A and Series B funding, licensed accelerator technology, and developed partnerships for clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library